T1	Participants 40 66	human platelet aggregation
T2	Participants 237 286	endothelial function and on platelet aggregation.
T3	Participants 443 515	40 aspirin-na√Øve volunteers with at least one cardiovascular risk factor
T4	Participants 613 711	20 patients with a prior diagnosis of coronary heart disease who were chronically assuming aspirin
